Anthem Blue Cross Blue Shield of Indiana policy

MED.00142 Gene Therapy for Cerebral Adrenoleukodystrophy

MED.00142 Gene Therapy for Cerebral Adrenoleukodystrophy is a public Anthem Blue Cross Blue Shield of Indiana policy (policy MED.00142). It lists 4 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Payer
Anthem Blue Cross Blue Shield of Indiana
Policy number
MED.00142
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes.

CodeOther Anthem Blue Cross Blue Shield of Indiana policies
38206Policies naming 38206
38232Policies naming 38232
38241Policies naming 38241
J3387Policies naming J3387

All Anthem Blue Cross Blue Shield of Indiana policies

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.